Skip to main content
OpenTrials
Completed

NCT Number: NCT03510065

Prevision® PMCF Study

Monocentric, non-interventional Post-Market Clinical Follow-Up (PMCF) Study on past implantations of the Prevision® prosthesis; the survival rate of the Prevision® prosthesis shall be evaluated and compared to literature results on comparable Revision stems.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum Bad Hersfeld

Bad Hersfeld, 36251, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion:

  • Patient received a Prevision® Hip Stem (curved or straight) between 2002 an 2012
  • Patient gave his written consent for study participation

Exclusion:

  • none

Treatment and study plan

Prevision®

Device

One time Evaluation with documentation of one follow-up visit

Primary outcomes

  1. Prevision® survival

    Time frame: 4-14 years after implantation

    Kaplan Meier Survival Rate, retrospective Analysis of Patients operated between 2002 and 2012

Secondary outcomes

  1. Clinical Results

    Time frame: 4-14 years after implantation

    Harris Hip Score: The score covers pain, function, absence of deformity, and range of motion. Pain is measured as pain severity and its effect on activities and need for pain medication.

    Hip function score consists of daily activities (stair use, using public transportation, sitting, and managing shoes and socks) and gait (limp, support needed, and walking distance). Deformity takes into account hip flexion, adduction, internal rotation, and extremity length discrepancy. Range of motion measures hip flexion, abduction, external and internal rotation, and adduction.

    There are 10 items. The score has a maximum of 100 points (best possible outcome) covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 points), and range of motion (2 items, 5 points).

  2. Ectopic Ossification

    Time frame: 4-14 years after implantation

    Radiological Results, Ectopic Ossification acc. to Brooker; retrospective Analysis of Patients operated between 2002 and 2012

  3. Sinking / Migration of the Stem

    Time frame: 4-14 years after implantation

    Radiological Results, Sinking / Migration of the Stem in [mm], Comparison to x-ray at Hospital discharge where available, retrospective Analysis of Patients operated between 2002 and 2012

  4. Radiological Evaluation of the Stem

    Time frame: 4-14 years after implantation

    Radiological Results of Radiolucent Lines, Osteolysis, Hypertrophy, Decrease of corticalis thickness, Cyst; retrospective Analysis of Patients operated between 2002 and 2012

  5. Quality of Life

    Time frame: 4-14 years after implantation

    Measured by EQ-5D-5L: The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L. The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).

    The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

  6. Pain

    Time frame: 4-14 years after implantation

    Pain in the hip Joint, measured by Visual Analogue Scale: The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points.

  7. Adverse Events

    Time frame: 4-14 years after implantation

    Documentation of any Adverse event

  8. Serious Adverse Events

    Time frame: 4-14 years after implantation

    Documentation of any Serious Adverse event

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Registry information

Official study title

Post Market Clinical Follow-Up Study Prevision®

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Apr 27, 2018
Registry last updated
Apr 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.